1. Introduction
===============

There has been a significant increase in the maternal age at childbirth in many developed countries.^\[[@R1],[@R2]\]^ A recent study reported that 20% of live births occurred in mothers aged 35 years or above.^\[[@R3]\]^ A similar trend of higher maternal age has also been observed in very low birth weight (VLBW, birth weight \<1500 g) preterm infants.^\[[@R2]\]^ Advanced maternal age considered as 35 years and above at childbirth has long been associated with numerous adverse maternal and perinatal outcomes.^\[[@R4]--[@R14]\]^ Older women are at increased risks for hypertension, diabetes, cardiovascular diseases, caesarean section, and the need for infertility treatments and assisted reproductive technology.^\[[@R4]--[@R12]\]^ Most studies have demonstrated higher incidences of multiple gestation, preterm birth, intrauterine growth restriction (IUGR), fetal malformations, intensive care unit admission, and neonatal death among infants born to older mothers.^\[[@R5]--[@R14]\]^ Delayed childbearing has long been associated with both congenital and acquired health concerns in the child, including Down syndrome, Alzheimer disease, hypertension, and diabetes.^\[[@R15]\]^ Most of these findings are primarily seen in infants born at term, and data are scarce for infants born prematurely, who are at higher risk for adverse outcomes.^\[[@R16]--[@R18]\]^ Recent studies have yielded inconsistent conclusions. Some studies have suggested a favorable effect of advanced maternal age on the neonatal mortality and morbidities among preterm infants.^\[[@R6],[@R16],[@R17]\]^

Given the rapid increase in the proportion of older motherhood and the limited evidence in literature, it is important to determine whether, and how, advanced maternal age is linked to the preterm infant\'s health and development beyond the neonatal stage. We hypothesized that advanced maternal age leads to adverse short-term and developmental outcomes among preterm infants. This study attempted to determine the short-term and long-term outcomes in VLBW preterm infants born to mothers with advanced age (≥35 years), compared to those born to younger mothers (20--34 years).

2. Methods
==========

2.1. General
------------

This retrospective cohort study was performed at a single, referral level III neonatal intensive care unit of MacKay Children\'s Hospital (Taipei, Taiwan). The medical charts of all VLBW infants during the period between August 2010 and November 2014 were retrospectively reviewed. Infants with major congenital anomalies were excluded. All data were obtained from the prospectively collected database of the Taiwan Premature Infant Developmental Collaborative Study Group. The study was approved by MacKay Memorial Hospital\'s Institutional Review Board (IRB number: 16MMHIS169e), with a waiver for informed consent. However, all patient records/information were anonymized and de-identified prior to analysis.

Infants were divided into the advanced maternal age group (maternal age ≥35 years) and comparison group (maternal age 20--34 years), based on the maternal age at childbirth. We collected data regarding the intrapartum and demographic variables. The use of antenatal steroids was defined as any dose of betamethasone administered before delivery. Premature rupture of membranes was defined as membrane rupture more than 18 hours prior to delivery. Clinical chorioamnionitis was diagnosed if the mother had fever, uterine fundal tenderness, and foul odor of the amniotic fluid. Small for gestational age was defined as birth weight less than the 10th percentile for gestational age. Delivery room resuscitation was defined as chest compression with or without administration of medications.

2.2. Short-term outcomes
------------------------

The short-term outcome variables included respiratory distress syndrome (RDS) requiring surfactant therapy, necrotizing enterocolitis (NEC) at Modified Bell\'s Stage ≥ II, severe intraventricular hemorrhage (IVH, grade III or IV), bronchopulmonary dysplasia (BPD, oxygen use at 28 days of life and at 36 weeks of postmenstrual age), patent ductus arteriosus (PDA) which required treatment, cystic periventricular leukomalacia (cPVL), culture-proven sepsis, retinopathy of prematurity (ROP) which required treatment, and neonatal mortality. Infants were diagnosed with sepsis if they had positive blood cultures for either bacteria or fungus. Neonatal mortality was defined as infant death before hospital discharge.

2.3. Long-term outcomes
-----------------------

Neurologic examinations and developmental outcomes were assessed at the 24th month of corrected age, but the protocol allowed a window of 23 to 25 months. The Bayley Scales of Infant Development, Third Edition (BSID-III) was the only tool used to evaluate developmental outcomes during the study period.^\[[@R19]\]^ The assessments were performed by a single, trained psychologist. The BSID-III contains 3 individual developmental scores: a cognitive composite score (CCS), a language composite score (LCS) (with receptive and expressive subscores), and a motor composite score (MCS) (with gross and fine motor subscores). Moderate to severe cerebral palsy (CP) was diagnosed when the child had nonprogressive motor impairment, characterized by abnormal muscle tone and abnormal control of movement or posture. Neurodevelopmental impairment (NDI) was defined as the presence of any of the following: CP, hearing loss in both ears requiring amplification, blindness in both eyes, MCS \< 85, or CCS \< 85. Severe NDI was defined as the presence of any of the following: CP, hearing loss in both ears requiring amplification, blindness in both eyes, MCS \< 70, or CCS \< 70. Composite outcomes of NDI and death were compared between the groups.

2.4. Statistical analysis
-------------------------

The crude risks were described as percentages. Unadjusted comparisons between categorical variables were analyzed using the Chi-squared test; continuous data were compared using the independent *t* test. Multivariate analyses were performed using the logistic regression model to estimate the relative risks of advanced maternal age on the long-term neurodevelopmental outcome of the cohort. Sociodemographic characteristics and perinatal conditions, including sex, gestational age, premature rupture of membrane, multiple births, resuscitation, antenatal steroid use, and maternal education, were included in the logistic regression models as potential confounders. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated for all outcomes if applicable. *P*-values were derived from Wald tests. All analyses were performed using Stata 15 (StataCorp, College Station, TX).

3. Results
==========

The study comprised 536 VLBW infants born to 483 mothers, of whom 190 (39.3%) were aged more than 35 years at childbirth, during the 4-year study period (Table [1](#T1){ref-type="table"}). Mothers of advanced age had a significantly lower proportion of primiparity compared to the other group (45.8% vs 65.2%, *P* \< .001), and were more likely to have gestational diabetes (13.7% vs 5.5%, *P* = .002) and to undergo IVF (18.4% vs 9.9%, *P* = .01).

###### 

Maternal and prenatal characteristics of mothers by maternal age group.
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Table [2](#T2){ref-type="table"} shows the neonatal characteristics and morbidities among the live births, by maternal age groups. More than half of the VLBW preterm infants were born to mothers between the ages of 20 and 35 years (61%). Infants in the 2 groups were comparable on demographic parameters, except for a marginally significant difference in the need for resuscitation between infants born to advanced age mothers and the comparison group (7.2% vs 3.6%, *P* = .07). There were no differences in the neonatal short-term outcomes between the groups, including RDS, pneumothorax, BPD, sepsis, NEC, ROP, PDA, IVH, cPVL, and death. A multivariable logistic regression model, which adjusted for the confounding factors, yielded the same results.

###### 

Neonatal characteristics of very low birth weight infants by maternal age group^∗^.
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Among all live births, 187 infants from the advanced maternal age group and 296 infants from the comparison group survived to a corrected age of 24 months. However, 27 infants in the advanced age group and 31 infants in the comparison group were lost to follow-up. The overall follow-up rate was 88%. The infants were assessed for neurodevelopment at a mean 24.4 ± 0.5 months of corrected age. Crude risk and relative risk estimates of the outcomes derived from the regression model are shown in Table [3](#T3){ref-type="table"}. There were no significant differences between the study groups in nutritional status, BSID-III cognitive or motor scores, incidence of bilateral blindness, hearing loss requiring amplification, and moderate to severe CP. The incidence of NDI and adverse composite outcomes were significantly higher in the advanced maternal age group, compared to the comparison group (28.8% vs 18.4%, *P* = .01; 37.4% vs 27.3%, *P* = .02, respectively). However, the logistic regression analysis showed that after controlling for potential confounding variables, the significance was diminished. The risk of severe speech delay (LCS \< 70) was also significantly higher in the advanced maternal age group (11.3% vs 5.7%, *P* = .04). This statistical difference remained consistent in the logistic regression analysis (aOR 2.27, 95% confidence interval \[CI\] 1.09--4.74, *P* = .03). To further investigate the effect of maternal age on severe speech delay in this population, the mothers were stratified into finer age groups: \<35, 35--40, and \>40 years. There was a trend of speech delay as the maternal age increased; however, no statistical significance was seen for the oldest maternal group (aOR for severe speech delay comparing mothers \>40 to \<35 years: 2.36, 95% CI 0.61--9.18, *P* = .216).

###### 

Nutritional and neurodevelopmental outcomes of the cohort by maternal age group.
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4. Discussion
=============

Delayed childbearing has been a growing trend over the past decades in many developed countries. In this cohort of VLBW preterm infants, 40% mothers gave birth at an advanced age. This proportion was higher than in a previous report of the general population.^\[[@R3]\]^ Against our hypothesis, we found that advanced maternal age did not affect any short-term outcomes. Although we found an association between advanced maternal age and severe speech delay, the neurodevelopmental and composite outcomes at 2 years of corrected age were not affected.

Pregnant women at an older age are at a higher risk for a range of complications. There are evidences that preeclampsia, pregnancy-associated hypertension, and caesarean section occurred more frequently in older pregnant women.^\[[@R5]--[@R11]\]^ A recent study reported that fetal exposure to maternal preeclampsia might reduce the risk of BPD in relatively mature VLBW infants.^\[[@R20]\]^ However, we did not find this association in our cohort. Compatible with results from previous researches in the general neonatal population, our study also found that mothers of VLBW infants who were at an advanced age were also at an increased risk for diabetes, and were more likely to conceive through IVF.^\[[@R5],[@R10]--[@R12]\]^ A systematic review of term babies suggested that maternal diabetes seemed to be negatively associated with the offspring\'s cognitive development during childhood.^\[[@R21]\]^ However, a recent large cohort study revealed that VLBW infants born to diabetic mothers did not appear to be at a higher risk of mortality or early morbidity, except for NEC.^\[[@R22],[@R23]\]^ VLBW infants conceived by IVF also exhibited a similar risk for mortality and morbidity compared to term infants.^\[[@R24]\]^

Among the full-term newborns born to mothers with advanced age, the incidences of multiple births, preterm birth, IUGR, congenital malformations, and neonatal death were reported to be higher.^\[[@R5]--[@R14]\]^ Many of the high risks could be explained by multiple pregnancy, preterm birth, or use of assisted conception. However, we did not find these associations in this study. On the contrary, most recent studies suggested that short-term morbidities and mortality of VLBW infants were not affected by advanced maternal age.^\[[@R16]--[@R18]\]^ One study even reported that the odds of survival improved, and the rates of mortality, NEC, and sepsis reduced as the maternal age increased.^\[[@R17]\]^ Based on evidences from the current and recent studies, advanced maternal age seems to have no significant effect on short-term outcomes in this vulnerable population.

To the best of our knowledge, this was the 1st study to report a correlation between severe speech delay, especially receptive language ability, and advanced maternal age. Speech and language impairments are common in preterm infants.^\[[@R25],[@R26]\]^ A study by the National Institutes of Child Health and Human Development (NICHD) reported that 20% of extremely low birth weight preterm infants had severe speech delay (composite score \<70).^\[[@R25]\]^ Speech and language development including expressive ability, receptive language processing, articulation, and phonologic memory are complex functions.^\[[@R26]\]^ Risk factors for preterm infants developing language impairment include low gestational age, IUGR, severe illness, and neonatal morbidities such as brain injury, feeding difficulty, duration of hospitalization, hearing capability, gender, and socioeconomic status.^\[[@R26],[@R27]\]^ Our result was inconsistent with that of a previous study conducted among term infants, which reported that language development improved with increasing maternal age.^\[[@R28]\]^ Further research is necessary to investigate the relationship between advanced maternal age and speech delay in VLBW infants.

For long-term outcomes, few data are available regarding the influence of advanced maternal age on subsequent neurodevelopment of the offspring. Few studies on the effects of older motherhood on the health and development beyond birth and the postnatal period of term infants reported mixed results.^\[[@R15],[@R28]--[@R30]\]^ Recent population-based cohort studies suggested that older maternal age might be beneficial for early child development.^\[[@R28]--[@R30]\]^ Contemporary older mothers tend to have a higher socioeconomic status, which might be related to higher education, higher family income, private health insurance, marital status, and are of lower parity than older mothers from earlier times. All these factors provide a more optimal environment and contribute to more favorable outcomes for children.^\[[@R6],[@R31]\]^ However, our study result suggested that advanced maternal age did not have a significant effect on neurodevelopment and composite outcomes at 2 years of corrected age. The probable reason could be that the causes of impairment in neurodevelopment are multifactorial. Maternal age is definitely one of these factors, but its causal role in long-term impairment is limited.

Our study is limited by its retrospective nature. The data also should be interpreted with caution due to the relatively small sample size and a single center population, which can lead to random bias. We did not have detailed information on the socioeconomic status, body mass index, placental weight, and behavioral factors such as smoking or alcohol consumption, which are known to be associated with maternal age and perinatal outcomes.^\[[@R6],[@R31],[@R32]\]^ Recent studies also indicated that not just maternal age, but advanced paternal age, might also affect the long-term health of the child.^\[[@R33]--[@R36]\]^ Additionally, longer follow-up might be needed in these infants since psychiatric disorders, such as poor social skills, schizophrenia, and autistic behaviors, have been linked to older parental age.^\[[@R33]--[@R36]\]^ Furthermore, our study sample was limited to VLBW infants, and the results might not apply to term infants or other populations of preterm infants.

In summary, in a VLBW preterm infant population, advanced maternal age was not associated with short-term morbidity and mortality. Long-term neurodevelopmental and composite outcomes at 2 years corrected age were also not affected by advanced maternal age. We found that maternal age was a risk factor for severe speech delay. However, from our data, we could not determine if older maternal age was the cause for severe speech delay or was merely representative of confounding. With a larger number of patients, the role of numerous confounding factors could be clarified. Future research with larger sample sizes involving multiple centers are necessary to minimize the random bias, and to determine whether the negative association is due to the advanced maternal age itself, or other older pregnancy related morbidities.
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